drugset

drugset / Trial / NCT00401648

Effect of Brivaracetam in Photosensitive Epileptic Subjects

NCT00401648 ↗

Phase 2 Completed 20 enrolled UCB Pharma

Non-randomizedSingle-groupSingle-blindTreatment

Summary

to assess the effect of brivaracetam on the photoparoxysmal EEG response in photosensitive epileptic subjects

Timeline

Start: 2002-09
Primary completion: 2003-06
Completion: 2003-06

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Brivaracetam	Small molecule	—	—

Indications